CEO and co-founder of BoostSuite
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and Chairman, Sycamore Networks
Professor of Systems Biology, Columbia University
Modes of administration other than oral or intravenous injection are usually preferred when drug delivery is directed to a specific tissue, such as the skin or eye. Non-traditional routes to systemic delivery, such as pulmonary, transdermal, transmuscosal, also promise substantial benefits. But they entail special delivery challenges. Biocom has organized a panel of local experts to discuss how these challenges are being overcome. More information and online registration is here.